Topics

Glioblastoma | Treatment | Nanotherapy

Home > Publications > Topics > Glioblastoma > Treatment > Nanotherapy

Bayoumi M, Youshia J, Arafa MG, Nasr M, Sammour OA.
Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade.
Arch Pharm (Weinheim). 2024 Jul 29:e2400343. doi: 10.1002/ardp.202400343. PMID: 39074966. Review˰ ˍ

Sarkar S, Greer J, Marlowe NJ, Medvid A, Ivan ME, Kolishetti N, Dhar S.
Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Aug 2;16(4):e1976. doi: 10.1002/wnan.1976. PMID: 39091260. Review. ˍ

Gawel AM, Betkowska A, Gajda E, Godlewska M, Gawel D.
Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment.
Biomedicines. 2024 Aug 11;12(8):1822. doi: 10.3390/biomedicines12081822. PMID: 39200286. Review. ˍ

Nanomicelles

Chithra P, Bhatia D, Solanki R.
Advanced nanomicelles for targeted glioblastoma multiforme therapy.
Biomater Adv. 2025 Feb 4;170:214221. doi: 10.1016/j.bioadv.2025.214221. PMID: 39922136. Review˰ ˍ

Qu M, Wang Q, Wang X, Tang J, Dong X, Zhao C, Guan Q.
Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy.
Nanomedicine (Lond). 2025 May 12;20(12):1495-1511. doi: 10.1080/17435889.2025.2503694. PMID: 40353316. Review˰ ˍ

Rahman MA, Yadab MK, Ali MM.
A modern approach to glioblastoma using temozolomide and nanoparticles carrier drug: a standard care of combination therapy and treatment.
Biochem Pharmacol. 2025 Aug 22;242(Pt 1):117276. doi: 10.1016/j.bcp.2025.117276. PMID: 40850359. Review˰ ˍ

Rana A, Mittal A, Vashist C, Sharma S, Rajput S, Sridhar SB, Malviya R.
Nanoparticle-Based Approaches for Glioblastoma Treatment: Advances and Future Prospects.
CNS Neurol Disord Drug Targets. 2025 Sep 22. doi: 10.2174/0118715273386112250912172648. PMID: 40993928. Review˰ ˍ